Ghent University Academic Bibliography

Journal Article
A1
open access

Preclinical in vivo-models to investigate HIPEC : current methodologies and challenges

Roxan F. C. P. A. Helderman, Daan R. Löke, Pieter J. Tanis, Jurriaan B. Tuynman, Wim Ceelen (UGent) , Ignace H. de Hingh, Kurt van der Speeten, Nicolaas A. P. Franken, Arlene L. Oei, H. Petra Kok, et al.

(2021) CANCERS. 13(14).

Add to list

Incidentally found mucinous epithelial tumors of the appendix with or without pseudomyxoma peritonei : diagnostic and therapeutic algorithms based on current evidence

Wim Ceelen (UGent) , Marc De Man (UGent) , Wouter Willaert (UGent) , Gabriëlle van Ramshorst, Karen Geboes (UGent) and Anne Hoorens (UGent)

(2021) ACTA CHIRURGICA BELGICA. 121(4). p.225-234

Add to list

Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) versus surgery without HIPEC for goblet-cell carcinoids and mixed adenoneuroendocrine carcinomas : propensity score-matched analysis of centers in the Netherlands and Belgium

Nina R. Sluiter, Jarmila D. van der Bilt, Dorothée M.R. Croll, Menno R. Vriens, Ignace H. J. T. de Hingh, Patrick Hemmer, Arend G. J. Aalbers, Andreas J. A. Bremers, Wim Ceelen (UGent) , Andre D’Hoore, et al.

(2020) CLINICAL COLORECTAL CANCER. 19(3). p.E87-E99

Add to list

Intraperitoneal chemotherapy for peritoneal metastases : an expert opinion

Wim Ceelen (UGent) , Helena Braet (UGent) , Gabrielle Van Ramshorst, Wouter Willaert (UGent) and Katrien Remaut (UGent)

(2020) EXPERT OPINION ON DRUG DELIVERY. 17(4). p.511-522

Add to list

Pooled analysis of the surgical treatment for colorectal cancer liver metastases

G Veereman, J Robays, L Verleye, R Leroy, C Rolfo, E Van Cutsem, D Bielen, Wim Ceelen (UGent) , E Danse, Marc De Man (UGent) , et al.

(2015) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 94(1). p.122-135

Add to list

Journal Article
A1
open access

Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model

Félix Gremonprez, Benedicte Descamps (UGent) , Andrei Izmer (UGent) , Christian Vanhove (UGent) , Frank Vanhaecke (UGent) , Olivier De Wever (UGent) and Wim Ceelen (UGent)

(2015) ONCOTARGET. 6(30). p.29889-29900

Add to list

Journal Article
A1
open access

BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis

Wouter Willaert (UGent) , Kurt Van Der Speeten, Gabriel Liberale and Wim Ceelen (UGent)

(2015) BMC CANCER. 15.

Add to list

Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis

Wim Ceelen (UGent) , Yves Van Nieuwenhove (UGent) , Dirk Van de Putte (UGent) and Piet Pattyn (UGent)

(2014) ANNALS OF SURGICAL ONCOLOGY. 21(9). p.3023-3028

Add to list

Journal Article
A1
open access

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer : the SIRFLOX study

Peter Gibbs, Val Gebski, Mark Van Buskirk, Kenneth Thurston, David N Cade, Guy A Van Hazel, the SIRFLOX Study group, Karen Geboes (UGent) and Marc Peeters (UGent)

(2014) BMC CANCER. 14.

Add to list

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases

SYLVIE DE BRUYNE (UGent) , Nancy Van Damme (UGent) , Peter Smeets (UGent) , Liesbeth Ferdinande (UGent) , Wim Ceelen (UGent) , Jeroen Mertens (UGent) , Christophe Van De Wiele (UGent) , Roberto Troisi (UGent) , Louis Libbrecht (UGent) , Stéphanie Laurent (UGent) , et al.

(2012) BRITISH JOURNAL OF CANCER. 106(12). p.1926-1933

Academic Bibliography

Preclinical in vivo-models to investigate HIPEC : current methodologies and challenges

Incidentally found mucinous epithelial tumors of the appendix with or without pseudomyxoma peritonei : diagnostic and therapeutic algorithms based on current evidence

Cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) versus surgery without HIPEC for goblet-cell carcinoids and mixed adenoneuroendocrine carcinomas : propensity score-matched analysis of centers in the Netherlands and Belgium

Intraperitoneal chemotherapy for peritoneal metastases : an expert opinion

Pooled analysis of the surgical treatment for colorectal cancer liver metastases

Pretreatment with VEGF(R)-inhibitors reduces interstitial fluid pressure, increases intraperitoneal chemotherapy drug penetration, and impedes tumor growth in a mouse colorectal carcinomatosis model

BEV-IP : perioperative chemotherapy with bevacizumab in patients undergoing cytoreduction and intraperitoneal chemoperfusion for colorectal carcinomatosis

Neoadjuvant chemotherapy with bevacizumab may improve outcome after cytoreduction and hyperthermic intraperitoneal chemoperfusion (HIPEC) for colorectal carcinomatosis

Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer : the SIRFLOX study

Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases

Contents

Support

Contact